Atlas FDA

Glaukos Corporation iStent Trabecular Micro-Bypass Stent System

FDA premarket approval P080030/S022 · decided 2018-12-18

Approval details

PMA number
P080030
Supplement
S022
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Glaukos Corporation iStent Trabecular Micro-Bypass Stent System
Generic name
Intraocular pressure lowering implant
Applicant
Glaukos Corporation
Date received
2018-11-21
Decision date
2018-12-18
Days to decision
27 days
Decision code
OK30
Product code
OGO
Advisory committee
Ophthalmic
Expedited review
No
Location
Laguna Hills, CA
Statement
Changes to the heparin coating procedure and in-process drying method for the iStent Trabecular Micro-Bypass Stent System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
iStent infinite Trabecular Micro-Bypass System, Model iS3 (K220032)Glaukos Corporation2022-08-02